Published in Emerg Infect Dis on September 01, 2002
Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. J Clin Microbiol (2003) 2.26
Francisella tularensis: an arthropod-borne pathogen. Vet Res (2008) 1.77
Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiol Infect (2007) 1.43
Re-emergence of Francisella tularensis in Germany: fatal tularaemia in a colony of semi-free-living marmosets (Callithrix jacchus). Epidemiol Infect (2007) 1.21
Transstadial transmission of Francisella tularensis holarctica in mosquitoes, Sweden. Emerg Infect Dis (2011) 1.01
Endemic tularemia, Sweden, 2003. Emerg Infect Dis (2005) 0.99
Effects of climate change on tularaemia disease activity in Sweden. Glob Health Action (2009) 0.94
Outbreaks of tularemia in a boreal forest region depends on mosquito prevalence. J Infect Dis (2011) 0.93
Experimental Infection of voles with Francisella tularensis indicates their amplification role in tularemia outbreaks. PLoS One (2014) 0.92
Detection of Francisella tularensis in Alaskan mosquitoes (Diptera: Culicidae) and assessment of a laboratory model for transmission. J Med Entomol (2010) 0.90
Detection of Francisella tularensis in voles in Finland. Vector Borne Zoonotic Dis (2014) 0.85
Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test. Clin Vaccine Immunol (2008) 0.83
Transmission of tularemia from a water source by transstadial maintenance in a mosquito vector. Sci Rep (2015) 0.80
Tularemia, a re-emerging infectious disease in Iran and neighboring countrie. Epidemiol Health (2015) 0.77
Binding and activation of host plasminogen on the surface of Francisella tularensis. BMC Microbiol (2010) 0.77
Epidemiology and ecology of tularemia in Sweden, 1984-2012. Emerg Infect Dis (2015) 0.77
Tularemia in children, Turkey, September 2009-November 2012. Emerg Infect Dis (2015) 0.75
Overwhelming sepsis after a cat bite. Can J Infect Dis Med Microbiol (2013) 0.75
Cat-bite-induced Francisella tularensis infection with a false-positive serological reaction for Bartonella quintana. JMM Case Rep (2017) 0.75
Case Report of Low Virulence Francisella tularensis Presented as Severe Bacteremic Pneumonia. Medicine (Baltimore) (2016) 0.75
An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med (2001) 4.60
Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) (1985) 2.67
Tularemia in North Carolina, 1965-1990. N C Med J (1995) 2.08
Airborne tularemia in Sweden. Scand J Infect Dis (1971) 1.83
Recent trends in the epidemiology of tularemia in the United States. J Infect Dis (1975) 1.53
Airborne transmission of tularemia in farmers. Scand J Infect Dis (1985) 1.52
Epidemiological analysis of tularemia in Sweden 1931-1993. FEMS Immunol Med Microbiol (1996) 1.46
Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987. Am J Epidemiol (1991) 1.44
An outbreak of tularemia in the northern part of central Sweden. Scand J Infect Dis (1984) 1.33
Tick-borne tularemia. An outbreak of lymphadenopathy in children. JAMA (1985) 1.33
Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis (1993) 1.22
Tularemia from domestic cats. West J Med (1993) 0.96
Treatment of tularemia with ciprofloxacin. Eur J Clin Microbiol Infect Dis (1992) 0.95
Ulceroglandular and pulmonary tularemia: a case resulting from a cat bite to the hand. J Hand Surg Am (1993) 0.94
Tularemia in the United States: epidemiologic aspects in the 1960s and follow-up of the outbreak of tularemia in Vermont. J Infect Dis (1970) 0.89
Tularemia in two cats. J Am Vet Med Assoc (1998) 0.86
Acute tularemia in three domestic cats. J Am Vet Med Assoc (1991) 0.84
Tularemia in a cat. J Vet Diagn Invest (1990) 0.84
Closure of schools during an influenza pandemic. Lancet Infect Dis (2009) 6.68
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet (2007) 5.50
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA (2009) 4.61
Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA (2011) 3.90
A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis (2007) 2.93
Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA (2012) 2.42
Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis (2010) 2.09
Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics (2002) 2.03
National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics (2006) 2.01
Malaria risk in travelers. Emerg Infect Dis (2005) 1.87
Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis (2008) 1.80
Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics (2008) 1.78
Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J (2002) 1.74
Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J (2006) 1.70
Emergence of parapneumonic empyema in the USA. Thorax (2011) 1.67
Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol (2007) 1.66
Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics (2007) 1.61
Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. J Am Coll Cardiol (2005) 1.57
Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J (2009) 1.55
An outbreak of gastrointestinal illness and erythema nodosum from grated carrots contaminated with Yersinia pseudotuberculosis. J Infect Dis (2006) 1.55
Bichat clinical guidelines for bioterrorist agents. Euro Surveill (2004) 1.54
Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis (2003) 1.50
Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med (2007) 1.46
One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS (2002) 1.44
Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney Int (2011) 1.43
A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis (2011) 1.42
Long-term survival after carotid endarterectomy for asymptomatic stenosis. Stroke (2006) 1.41
Intervening to reduce inequalities in infections in Europe. Am J Public Health (2008) 1.41
Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med (2009) 1.41
[Better treatment has reduced AIDS mortality. Increased number of patients with HIV infections will burden the ambulatory care services]. Lakartidningen (2002) 1.40
Timeliness of case reporting in the Swedish statutory surveillance of communicable diseases 1998--2002. Scand J Infect Dis (2004) 1.37
International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Emerg Infect Dis (2008) 1.34
Risk factors for domestic sporadic campylobacteriosis among young children in Sweden. Scand J Infect Dis (2005) 1.34
Internet use and epidemiologic investigation of gastroenteritis outbreak. Emerg Infect Dis (2004) 1.32
Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis (2002) 1.29
Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill (2004) 1.29
Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry. Circ Cardiovasc Interv (2009) 1.25
Emerging genotype (GGIIb) of norovirus in drinking water, Sweden. Emerg Infect Dis (2003) 1.24
Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis (2008) 1.24
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am J Cardiol (2010) 1.20
Parents' reported reasons for avoiding MMR vaccination. A telephone survey. Scand J Prim Health Care (2005) 1.11
Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis. Euro Surveill (2004) 1.10
Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J (2013) 1.10
[Time for booster doses against whooping cough for 10-year-old children]. Lakartidningen (2005) 1.07
Risk of invasive pneumococcal infections among working age adults with asthma. Thorax (2010) 1.05
Invasive group B streptococcal infections in Finland: a population-based study. Emerg Infect Dis (2003) 1.03
Some model based considerations on observing generation times for communicable diseases. Math Biosci (2009) 1.02
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol (2006) 1.02
Endemic tularemia, Sweden, 2003. Emerg Infect Dis (2005) 0.99
Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr (2006) 0.99
Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis. Euro Surveill (2004) 0.98
Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies. BMC Infect Dis (2008) 0.98
Timeliness of MMR vaccination--influence on vaccination coverage. Vaccine (2004) 0.98
Proposed new International Health Regulations. BMJ (2005) 0.98
Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey. Pediatrics (2007) 0.97
Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia. Euro Surveill (2004) 0.97
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). J Am Coll Cardiol (2009) 0.96
Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: Results from a population-based registry. J Vasc Surg (2006) 0.96
Linking environmental drivers to infectious diseases: the European environment and epidemiology network. PLoS Negl Trop Dis (2013) 0.93
Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis (2009) 0.92
Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction. Am Heart J (2005) 0.92
Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block. Circulation (2004) 0.92
Rickettsioses in Swedish travellers, 1997-2001. Scand J Infect Dis (2003) 0.92
Risk factors for developing tuberculosis in remand prisons in St. Petersburg, Russia - a case-control study. Eur J Epidemiol (2007) 0.92
Size matters -- patient organisations exaggerate prevalence numbers. Eur J Epidemiol (2005) 0.91
Travellers returning to Sweden as sentinels for comparative disease incidence in other European countries, campylobacter and giardia infection as examples. Euro Surveill (2004) 0.90
Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness. Vaccine (2011) 0.90
Emergence of new Salmonella Enteritidis phage types in Europe? Surveillance of infections in returning travellers. BMC Med (2004) 0.89
Mortality following Campylobacter infection: a registry-based linkage study. BMC Infect Dis (2005) 0.89
Sindbis virus infection in resident birds, migratory birds, and humans, Finland. Emerg Infect Dis (2008) 0.89
Epidemiological investigation of a food-borne gastroenteritis outbreak caused by Norwalk-like virus in 30 day-care centres. Scand J Infect Dis (2002) 0.89
Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008. Am J Prev Med (2010) 0.89
Bichat guidelines for the clinical management of plague and bioterrorism-related plague. Euro Surveill (2004) 0.88
Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings. Vaccine (2008) 0.88
Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax. Euro Surveill (2004) 0.87
A newborn with domestically acquired legionnaires disease confirmed by molecular typing. Clin Infect Dis (2002) 0.86
The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine (2011) 0.86
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. J Am Coll Cardiol (2009) 0.86
Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy. Scand J Infect Dis (2014) 0.86
Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever. Euro Surveill (2004) 0.86
Population density and mortality among individuals in motor vehicle crashes. Inj Prev (2010) 0.85
Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007. Foodborne Pathog Dis (2008) 0.85
Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis (2008) 0.85
Modelling the spread of penicillin-resistant Streptococcus pneumoniae in day-care and evaluation of intervention. Stat Med (2005) 0.84
The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms--a prospective randomized double-blind trial. J Vasc Surg (2009) 0.84
Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem (2004) 0.83